Hematopathology Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Haematologica. 2019 Sep;104(9):1822-1829. doi: 10.3324/haematol.2018.207928. Epub 2019 Feb 7.
Burkitt-like lymphoma with 11q aberration is characterized by pathological features and gene expression profile resembling those of Burkitt lymphoma but lacks the rearrangement and carries an 11q-arm aberration with proximal gains and telomeric losses. Whether this lymphoma is a distinct category or a particular variant of other recognized entities is controversial. To improve the understanding of Burkitt-like lymphoma with 11q aberration we performed an analysis of copy number alterations and targeted sequencing of a large panel of B-cell lymphoma-related genes in 11 cases. Most patients had localized nodal disease and a favorable outcome after therapy. Histologically, they were high grade B-cell lymphoma, not otherwise specified (8 cases), diffuse large B-cell lymphoma (2 cases) and only one was considered as atypical Burkitt lymphoma. All cases had a germinal center B-cell signature and phenotype with frequent LMO2 expression. The patients with Burkitt-like lymphoma with 11q aberration had frequent gains of 12q12-q21.1 and losses of 6q12.1-q21, and lacked common Burkitt lymphoma or diffuse large B-cell lymphoma alterations. Potential driver mutations were found in 27 genes, particularly involving , , , , and However, , , or mutations were absent in all cases. These results suggest that Burkitt-like lymphoma with 11q aberration is a germinal center-derived lymphoma closer to high-grade B-cell lymphoma or diffuse large B-cell lymphoma than to Burkitt lymphoma.
具有 11q 异常的伯基特样淋巴瘤的特征在于病理特征和基因表达谱类似于伯基特淋巴瘤,但缺乏重排,并且具有 11q 臂异常,近端增益和端粒丢失。这种淋巴瘤是否是一个独特的类别还是其他公认实体的特定变体存在争议。为了更好地了解具有 11q 异常的伯基特样淋巴瘤,我们对 11 例病例进行了拷贝数改变分析和大量 B 细胞淋巴瘤相关基因的靶向测序。大多数患者具有局部淋巴结疾病,并且在治疗后预后良好。组织学上,它们是高级别 B 细胞淋巴瘤,未另作说明(8 例),弥漫性大 B 细胞淋巴瘤(2 例),只有 1 例被认为是非典型伯基特淋巴瘤。所有病例均具有生发中心 B 细胞特征和表型,并且频繁表达 LMO2。具有 11q 异常的伯基特样淋巴瘤患者经常出现 12q12-q21.1 的增益和 6q12.1-q21 的丢失,并且缺乏常见的伯基特淋巴瘤或弥漫性大 B 细胞淋巴瘤改变。在 27 个基因中发现了潜在的驱动突变,特别是涉及 、 、 、 和 ,然而,所有病例均不存在 、 、 或 突变。这些结果表明,具有 11q 异常的伯基特样淋巴瘤是一种生发中心来源的淋巴瘤,与高级别 B 细胞淋巴瘤或弥漫性大 B 细胞淋巴瘤比伯基特淋巴瘤更接近。